ArticleEuropean journal of pediatrics2025
Effects of metabolic syndrome and its components on pulmonary function and functional capacity in children and adolescents with obesity.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Sustainable Plant-Based Diets in Children and Adolescents: Current Evidence on Metabolic Syndrome and Cardiometabolic Health.Current nutrition reports · 2026Review
- Phenotypic characterization of treatment-naïve childhood asthma with obesity: features of lung function, inflammation, and lipid profiles.European journal of pediatrics · 2026Article
- The moderating effect of body mass index on the association between lung function and physical fitness among adolescents.Frontiers in public health · 2026Article
- Critical appraisal of "Effects of metabolic syndrome and its components on pulmonary function and functional capacity in children and adolescents with obesity".European journal of pediatrics · 2025Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
Obesity is a pervasive global health issue frequently associated with metabolic syndrome (MetS). Limited data exist regarding the impact of MetS and its individual components on pulmonary function in obese pediatric populations. This study investigated the relationship between MetS and lung function, and further identified specific MetS components that adversely affect pulmonary outcomes. We enrolled obese children and adolescents aged 7‒18 years. Anthropometric measurements and metabolic assessments were performed. All participants underwent spirometry and the six-minute walk test (6-MWT). Based on MetS criteria, participants were classified into MetS or non-MetS groups. Between-group comparisons were conducted, and regression analyses were used to identify MetS components predictive of lung function and exercise capacity. A total of 155 participants were evaluated (37 [23.9%] with MetS; 118 [76.1%] without). Those with MetS demonstrated a significantly lower 6-MWT distance z-score (‒0.61 ± 1.1 vs ‒0.07 ± 0.99; P = 0.006). No significant group differences were found in spirometric parameters. Obesity indices exerted a stronger negative effect on lung function than MetS status. Abdominal circumference (b = ‒0.03, P < 0.001) and elevated FBS (> 100 mg/dL; b = ‒0.50, P = 0.04) were associated with reduced 6-MWT distance z-scores; they also negatively influenced FEV1% predicted (abdominal circumference: b = ‒0.15, P < 0.04; elevated FBS: b = ‒9.04, P = 0.02).
conclusionsObese children and adolescents with MetS show significantly diminished functional capacity as evidenced by lower 6-MWT performance. Among MetS components, increased abdominal circumference and elevated FBS (> 100 mg/dL) emerged as critical predictors of decreased functional capacity. WHAT IS KNOWN: • Obesity is associated with metabolic syndrome (MetS) and is known to impair lung function. • MetS is linked to metabolic and cardiovascular complications, but its impact on pulmonary function in obese pediatric populations remains unclear. WHAT IS NEW: • Obese children and adolescents with MetS have significantly lower functional capacity, as demonstrated by reduced six-minute walk test (6-MWT) performance. • Among MetS components, increased abdominal circumference and elevated fasting blood sugar > 100 mg/dL were identified as key predictors of reduced functional capacity and lung function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.